TCM
REGN icon

Telos Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Telos Capital Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$310K Buy
497
+15
+3% +$10.2K 0.03% 169
2026
Q1 		$372K Sell
482
-3
-0.6% -$2.3K 0.04% 157
2025
Q4 		$374K Sell
485
-3
-0.6% -$2.04K 0.03% 160
2025
Q3 		$274K Buy
488
+6
+1% +$3.39K 0.03% 168
2025
Q2 		$253K Buy
+482
New +$269K 0.03% 182
2025
Q1 		– Sell
-301
Closed -$214K – 201
2024
Q4 		$214K Sell
301
-41
-12% -$34.4K 0.02% 190
2024
Q3 		$360K Hold
342
– – 0.04% 163
2024
Q2 		$359K Sell
342
-1
-0.3% -$969 0.04% 160
2024
Q1 		$330K Sell
343
-1
-0.3% -$951 0.04% 164
2023
Q4 		$302K Sell
344
-11
-3% -$9.06K 0.04% 172
2023
Q3 		$292K Sell
355
-17
-5% -$13.4K 0.04% 157
2023
Q2 		$267K Sell
372
-7
-2% -$5.4K 0.04% 173
2023
Q1 		$311K Sell
379
-41
-10% -$30.9K 0.04% 157
2022
Q4 		$303K Buy
420
+96
+30% +$70.8K 0.04% 159
2022
Q3 		$223K Buy
+324
New +$204K 0.04% 159
2022
Q2 		– Sell
-333
Closed -$233K – 184
2022
Q1 		$233K Buy
333
+3
+0.9% +$1.9K 0.03% 168
2021
Q4 		$208K Sell
330
-2
-0.6% -$1.23K 0.03% 184
2021
Q3 		$201K Buy
+332
New +$206K 0.03% 178

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Telos Capital Management's REGN Position: Q2 2026 in Review

Telos Capital Management increased its Regeneron Pharmaceuticals (REGN) stake by 3.1% in Q2 2026, buying an estimated $10.2K and bringing the position to 497 shares worth $310K. The position accounts for 0.03% of the portfolio, ranked #169.

Telos Capital Management first reported a position in REGN in Q3 2021 and has held it in 18 quarters since. The position peaked at $374K in Q4 2025. 373 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Telos Capital Management held 497 shares of Regeneron Pharmaceuticals worth $310K as of Q2 2026.
  • Telos Capital Management bought 15 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $10.2K.
  • Regeneron Pharmaceuticals made up 0.03% of Telos Capital Management's portfolio in Q2 2026, its #169 holding.
  • Telos Capital Management first reported a position in Regeneron Pharmaceuticals in Q3 2021 and has held it in 18 quarters since.
  • Telos Capital Management's Regeneron Pharmaceuticals position peaked at $374K in Q4 2025.
  • 373 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Telos Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.